• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form NT 10-K filed by Brilliant Acquisition Corporation

    1/2/24 4:52:26 PM ET
    $BRLI
    Blank Checks
    Finance
    Get the next $BRLI alert in real time by email
    NT 10-K 1 ea191002-nt10k_nukkleusinc.htm NOTIFICATION OF LATE FILING

     

     

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

      FORM 12b-25

    SEC FILE NUMBER

    001-39341 

       
         
       

    CUSIP NUMBER

    67054R 104

    67054R 112

      NOTIFICATION OF LATE FILING  

     

    (Check One):     ☒  Form 10-K   ☐  Form 20-F   ☐  Form 11-K  ☐   Form 10-Q   ☐   Form N-SAR   ☐  Form N-CAR

     

    For Period Ended: September 30, 2023

     

    ☐ Transition Report on Form 10-K

    ☐ Transition Report on Form 20-F

    ☐ Transition Report on Form 11-K

    ☐ Transition Report on Form 10-Q

    ☐ Transition Report on Form N-SAR

     

    For the Transition Period Ended: ________________________________________________________

     

    Read Instruction (on back page) Before Preparing Form. Please Print or Type.

    Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

     

    If the notification relates to a portion of the filing checked above, identify the item(s) to which the notification relates:

     

     

     

    PART I - REGISTRANT INFORMATION

     

    Nukkleus Inc.

     

    Full name of registrant

     

     

     

    Former name if applicable

     

    525 Washington Blvd.

     

    Address of principal executive office

     

    Jersey City, New Jersey 07310

     

    City, state and zip code

     

     

     

     

    PART II - RULE 12b-25 (b) AND (c)

     

    If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25 (b), the following should be completed. (Check box if appropriate.)

     

        (a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
    ☒   (b) The subject annual report, semi-annual report, transition report on Form 10-K, 20-F, 11-K, Form N-SAR, Form N-CSR, or portion thereof, will be filed on or before the 15th calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q, or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
        (c)   The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

      

    PART III

    NARRATIVE

     

    State below in reasonable detail the reasons why Form 10-K, 11-K, 20-F, 10-Q, N-SAR or the transition report portion thereof could not be filed within the prescribed time period.

     

    The Company’s Annual Report on Form 10-K for the annual period ended September 30, 2023 cannot be filed within the prescribed time period because the Company’s auditor was recently acquired and requires additional time to review certain information required to be included in the Form 10-K. The Company’s Annual Report on Form 10-K will be filed on or before the 15th calendar day following the prescribed due date.

     

    Part IV

    Other Information

     

    (1) Name and telephone number of person to contact in regard to this notification

     

    Emil Assentato, CEO   (212)   791-4663
    (Name)   (Area Code)   (Telephone Number)

     

    (2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify report(s).

     

    ☒ Yes ☐ No

     

    (3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?

     

    ☐ Yes ☒ No

     

    If so: attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

     

    2

     

     

    Nukkleus Inc.

     

    Name of Registrant as Specified in Charter.

     

    Has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.

     

    Date: January 2, 2024 By: /s/ Emil Assentato
        Emil Assentato
        Chief Executive Officer

     

     

    3

     

     

    Get the next $BRLI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BRLI

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $BRLI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4: Shen Yebo acquired 5,000 units of Ordinary Shares

    4 - Brilliant Acquisition Corp (0001787518) (Issuer)

    4/21/22 7:00:25 PM ET
    $BRLI
    Blank Checks
    Finance

    SEC Form 4: Ferrier Brian acquired 5,000 units of Ordinary Shares

    4 - Brilliant Acquisition Corp (0001787518) (Issuer)

    4/20/22 9:00:30 PM ET
    $BRLI
    Blank Checks
    Finance

    SEC Form 3 filed by new insider Ferrier Brian

    3 - Brilliant Acquisition Corp (0001787518) (Issuer)

    3/11/22 8:21:59 PM ET
    $BRLI
    Blank Checks
    Finance

    $BRLI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Nukkleus Inc. Closes Merger with Brilliant Acquisition Corporation

    NEW YORK, Dec. 22, 2023 /PRNewswire/ -- Nukkleus Inc. (NASDAQ:NUKK) proudly announces the closing of its strategic merger with Brilliant Acquisition Corporation. This merger, valuing Nukkleus at around $105 million, signifies a bold step into a future rich with digital asset opportunities for businesses and investors alike.  The combined company has been redomesticated to Delaware and its name has been change to Nukkleus Inc.  The common stock and warrants of the combined company are expected to begin trading on the Nasdaq Stock Market under the ticker symbols NUKK and NUKKW on December 26, 2023.  Merger Details and Future Prospects Nukkleus has undergone a strategic evolution through a SPA

    12/22/23 9:27:00 PM ET
    $BRLI
    Blank Checks
    Finance

    Nukkleus, Inc. Finalizes Transformative Merger with Brilliant Acquisition Corp, Unveiling New Horizons in Digital Asset Solutions for Customers

    NEW YORK, Nov. 30, 2023 /PRNewswire/ -- Nukkleus, Inc. (formerly Compliance & Risk Management Solutions Inc.) (OTC:NUKK) proudly announces the completion of its strategic merger with Brilliant Acquisition Corp (NASDAQ:BRLI), marking a significant milestone in the financial technology landscape. This merger, valuing Nukkleus at around $105 million, signifies a bold step into a future rich with digital asset opportunities for businesses and investors alike. Strategic Insight from Nukkleus Management Emil Assentato, CEO & Chairman of Nukkleus, reflects on this landmark event: "Th

    11/30/23 9:00:00 AM ET
    $BRLI
    Blank Checks
    Finance

    Brilliant Acquisition Corporation Announces Extension of Completion Window to December 23, 2023

    New York, Nov. 22, 2023 (GLOBE NEWSWIRE) -- Brilliant Acquisition Corporation ("Brilliant") announced today that it has extended the period of time it will have to consummate its initial business combination by a further one month, or until December 23, 2023. In connection with the extension, Brilliant's Sponsor, Nisun Investment Holding Limited, and Nukkleus Inc. ("Nukkleus") deposited an aggregate of $32,300 in Brilliant's trust account, representing $0.08 per public ordinary share of Brilliant currently outstanding, as additional interest on the proceeds in the trust account. The extension was approved by Brilliant's shareholders on July 20, 2023. The purpose of the extension is to p

    11/22/23 4:16:38 PM ET
    $BRLI
    Blank Checks
    Finance

    $BRLI
    SEC Filings

    View All

    Brilliant Acquisition Corporation filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Nukkleus Inc. (0001787518) (Filer)

    1/26/24 5:15:36 PM ET
    $BRLI
    Blank Checks
    Finance

    Brilliant Acquisition Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Nukkleus Inc. (0001787518) (Filer)

    1/17/24 9:21:33 AM ET
    $BRLI
    Blank Checks
    Finance

    Brilliant Acquisition Corporation filed SEC Form 8-K: Other Events

    8-K - Nukkleus Inc. (0001787518) (Filer)

    1/11/24 5:16:25 PM ET
    $BRLI
    Blank Checks
    Finance

    $BRLI
    Financials

    Live finance-specific insights

    View All

    Nukkleus Reports Year End Financial Results and Continues Focus on SPAC Merger with Brilliant Acquisition Corp.

    Nukkleus Inc (OTC:NUKK) ("Nukkleus") filed its annual report on Form 10-K for the year ended September 30, 2022, with the Securities and Exchange Commission and continues to focus its efforts on completing its previously announced merger with Brilliant Acquisition Corp. (NASDAQ:BRLI) ("Brilliant"). The financial results demonstrate that digitalRFQ (DRFQ), a subsidiary of Nukkleus, has seen significant growth in trading volume over the 12 months to September 30, 2022, transacting over $350 million in digital asset cross-border payments for the year ended September 30, 2022. This growth can be attributed to robust technology, client acquisition, strong customer retention and increased trans

    4/17/23 4:00:00 PM ET
    $BRLI
    Blank Checks
    Finance

    $BRLI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Brilliant Acquisition Corporation

    SC 13G - Nukkleus Inc. (0001787518) (Subject)

    2/13/24 3:02:25 PM ET
    $BRLI
    Blank Checks
    Finance

    SEC Form SC 13G/A filed by Brilliant Acquisition Corporation (Amendment)

    SC 13G/A - Brilliant Acquisition Corp (0001787518) (Subject)

    2/7/23 4:38:31 PM ET
    $BRLI
    Blank Checks
    Finance

    SEC Form SC 13G/A filed by Brilliant Acquisition Corporation (Amendment)

    SC 13G/A - Brilliant Acquisition Corp (0001787518) (Subject)

    11/10/22 4:09:03 PM ET
    $BRLI
    Blank Checks
    Finance